Back to results
US 2022/0088057 A1Published application
Therapeutic agent for fibrosis
AssigneeKyorin Pharmaceutical Co., Ltd.
InventorsKazuhisa NAKAO, Junichi ISHIYAMA, Wataru ICHIKAWA, Atsushi MASUI, Yunike AKASAKA, Aya HONDA
Life of this patent
Estimating the term…
Abstract
Disclosed is an antisense nucleic acid that suppresses NEK6 gene expression.
Claims10
1-5. (canceled)
A method for inhibiting phosphorylation of SMAD2/3 protein, comprising administering an antisense nucleic acid that suppresses NEK6 gene expression to a subject in need thereof.
A method for treating fibrosis, comprising administering an antisense nucleic acid that suppresses NEK6 gene expression to a subject in need thereof.
Dependencies are inferred from the claim text.